India's biotechnology leader Biocon is caught up in a controversy. Villagers allege the company has polluted air and ground water in the Hebbagodi region, where the company's factory is located. In fact they took out a protest march.
The new division is being set up to focus on brand building.
http://www.ibnlive.com/news/biocon-net-up-75-in-q4-at-rs-6530-cr/63756-7.html
Biocon has entered into partnership with Bristol-Myers Squibb to provide research for development of drugs.
http://www.ibnlive.com/news/biocon-us-firm-tieup-for-drug-research/36031-7.html
After launching a drug for solid tumours, India's leading biotech firm Biocon will launch a new anti-arthritis drug.
http://www.ibnlive.com/news/biocon-to-launch-antiarthritis-drug-soon/27200-17.html
Biocon has unveiled BIOMAb-EGFR, a therapeutic antibody-based drug for treating tumours of epithelial origin.
http://www.ibnlive.com/news/biocon-unveils-innovative-cancer-drug/21901-17.html
Biotechnology major Biocon Ltd seeks DCGI's approval for new drug for treatment of head and neck cancer.
http://www.ibnlive.com/news/dcgi-approval-for-cancer-drug-biocon/8984-17.html
Biotech giant Biocon has lowered its profit forecasts for the current fiscal. It says profits may fall a bit due to higher depreciation charges.
http://www.ibnlive.com/news/biocon-lowers-profit-guidance/2374-16.html
 |
|
